ArticleScientific reports2026

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.

Benjamin Chaussin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.